Non Animal Testing Database
EnglischDeutsch

Large-scale machine learning cancer genome analysis for therapeutic target identification

2018
Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
The authors describe and evaluate a combination of transcriptomics and machine-learning approaches to classifying aberrant pathway activity in tumors.This may aid identifying patients who will respond well to a certain anticancer therapy. The algorithm integrates RNA-seq, copy number, and mutations from 33 different cancer types across The Cancer Genome Atlas (TCGA) PanCanAtlas project to predict aberrant molecular states in tumors. Potential biomarkers for choosing cancer treatment are identified.
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas
Casey S. Greene
#15
Added on: 04-21-2020
Back to Top
English German

Warning: Internet Explorer

The IE from MS no longer understands current scripting languages, the latest main version (version 11) is from 2013 and has not been further developed since 2015.

Our recommendation: Use only the latest versions of modern browsers, for example Google Chrome, Mozilla Firefox or Microsofrt Edge, because only this guarantees you sufficient protection against infections and the correct display of websites!